SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

R J Bio-Tech informs about disclosure

15 Mar 2024 Evaluate
R J Bio-Tech has informed that the Hon’ble National Company Law Tribunal, Mumbai Bench has admitted R J Bio-tech (Company) into corporate insolvency resolution process by way of its order dated 20th September, 2022 (CIRP Admission Order) under the provisions of the Insolvency and Bankruptcy Code, 2016 read with the underlying Regulations Anurag Kumar Sinha was initially appointed as the interim resolution professional of the Company. Pursuant to decision taken by the committee of creditors (CoC) of the Company, he was later appointed as Resolution Professional. Further, the CoC in their 24th meeting held on 03rd January 2024 and continued on 10th January 2024 approved the appointment of Harish Kant Kaushik, an Insolvency Professional, having IBBI Registration Number: IBBI/IPA-001/P-01469/2018- 2019/12340 as a liquidator and the same is confirmed by National Company Law Tribunal vide order dated 29th February 2024. Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (LODR) and in accordance with the requirements of sub-clause 16(d) of Clause A of Part A of Schedule III of LODR, they attached FORM B -Public Announcement -For submission of claims of stakeholders in R J Bio-Tech, published on 8th March 2024 in the Newspapers Financial Express–English, Navakal- Marathi and The Indian Express-English and on 9th March 2024 in Loksatta-Marathi.

The above information is a part of company’s filings submitted to BSE.

RJ Bio-Tech Share Price

3.43 0.00 (0.00%)
01-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Venkys India 1630.95
Mangalam Global Ent 14.24
Kaveri Seed 989.10
Regaal Resources 95.67
Simran Farms 169.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×